ACT Genomics

ACTG provides optimal cancer treatment plan, cancer relapse and drug resistance monitoring as well as cancer risk assessment and immunotherapy evaluation. The company achieves precise cancer genetic variants detection with minimum tumor samples, and delivers to every cancer patient personalized genomic information based-treatment plans through cutting-edge NGS platform, medical report and integrated services.